{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:31:01Z","timestamp":1791354661048,"version":"4.3.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS086444"],"award-info":[{"award-number":["NS086444"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS111351"],"award-info":[{"award-number":["NS111351"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke"},{"DOI":"10.13039\/100006346","name":"Hope for Depression Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1038\/s41386-023-01645-w","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T17:03:22Z","timestamp":1689872602000},"page":"1680-1689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain"],"prefix":"10.1038","volume":"48","author":[{"given":"Randal A.","family":"Serafini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Estill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8825-2565","authenticated-orcid":false,"given":"Elizabeth A.","family":"Pekarskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Sakloth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5190-2851","authenticated-orcid":false,"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Javitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venetia","family":"Zachariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"1645_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","volume":"67","author":"J Dahlhamer","year":"2018","unstructured":"Dahlhamer J, Lucas J, Zelaya C, Nahin R, Mackey S, DeBar L, et al. Prevalence of chronic pain and high-impact chronic pain among adults\u2014United States, 2016. Morb Mortal Wkly Rep. 2018;67:1001\u20136.","journal-title":"Morb Mortal Wkly Rep"},{"key":"1645_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895\u2013926.","journal-title":"J Pain"},{"key":"1645_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biopsych.2019.10.018","volume":"87","author":"RA Serafini","year":"2020","unstructured":"Serafini RA, Pryce KD, Zachariou V. The mesolimbic dopamine system in chronic pain and associated affective comorbidities. Biol Psychiatry. 2020;87:64\u201373.","journal-title":"Biol Psychiatry"},{"key":"1645_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.31887\/DCNS.2008.10.4\/kkelly","volume":"10","author":"K Kelly","year":"2008","unstructured":"Kelly K, Posternak M, Alpert JE. Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci. 2008;10:409\u201318.","journal-title":"Dialogues Clin Neurosci"},{"key":"1645_CR5","first-page":"16","volume":"62","author":"AC Swann","year":"2001","unstructured":"Swann AC. Major system toxicities and side effects of anticonvulsants. J Clin Psychiatry. 2001;62:16\u201321.","journal-title":"J Clin Psychiatry"},{"key":"1645_CR6","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","volume":"11","author":"R Benyamin","year":"2008","unstructured":"Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, et al. Opioid complications and side effects. Pain Physician. 2008;11:S105\u201320.","journal-title":"Pain Physician"},{"key":"1645_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0924-9338(02)00651-X","volume":"17","author":"S Kasper","year":"2002","unstructured":"Kasper S, Oli\u00e9 JP. A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression. Eur Psychiatry. 2002;17:331\u201340.","journal-title":"Eur Psychiatry"},{"key":"1645_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00004714-200304000-00008","volume":"23","author":"T Nickel","year":"2003","unstructured":"Nickel T, Sonntag A, Schill J, Zobel AW, Ackl N, Brunnauer A, et al. Clinical and neurobiological effects of tianeptine and paroxetine in major depression. J Clin Psychopharmacol. 2003;23:155\u201368.","journal-title":"J Clin Psychopharmacol"},{"key":"1645_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejphar.2012.01.043","volume":"681","author":"SS Bilge","year":"2012","unstructured":"Bilge SS, Bozkurt A, Ilkaya F, \u00c7iftcio\u01e7lu E, Kesim Y, Uzbay TI. The antinociceptive effects of intravenous tianeptine in colorectal distension-induced visceral pain in rats: the role of 5-HT 3 receptors. Eur J Pharm. 2012;681:44\u20139.","journal-title":"Eur J Pharm"},{"key":"1645_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neulet.2016.09.022","volume":"633","author":"BH Heo","year":"2016","unstructured":"Heo BH, Shin JY, Park KS, Lee HG, Choi JI, Yoon MH, et al. Effects of tianeptine on the development and maintenance of mechanical allodynia in a rat model of neuropathic pain. Neurosci Lett. 2016;633:82\u20136.","journal-title":"Neurosci Lett"},{"key":"1645_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1213\/ANE.0b013e31824181e7","volume":"114","author":"WM Kim","year":"2012","unstructured":"Kim WM, Lee SH, Jeong HJ, Lee HG, Choi JI, Yoon MH. The analgesic activity of intrathecal tianeptine, an atypical antidepressant, in a rat model of inflammatory pain. Anesth Analg. 2012;114:683\u20139.","journal-title":"Anesth Analg"},{"key":"1645_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1046\/j.1460-9568.2002.02136.x","volume":"16","author":"MHP Kole","year":"2002","unstructured":"Kole MHP, Swan L, Fuchs E. The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur J Neurosci. 2002;16:807\u201316.","journal-title":"Eur J Neurosci"},{"key":"1645_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1460-9568.2007.05952.x","volume":"26","author":"P Svenningsson","year":"2007","unstructured":"Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M, et al. Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci. 2007;26:509\u201317.","journal-title":"Eur J Neurosci"},{"key":"1645_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/mp.2009.80","volume":"15","author":"BS McEwen","year":"2010","unstructured":"McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, et al. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry. 2010;15:237\u201349.","journal-title":"Mol Psychiatry"},{"key":"1645_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1067\/S1526-5900(03)00781-8","volume":"4","author":"SD Shields","year":"2003","unstructured":"Shields SD, Eckert WA, Basbaum AI. Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis. J Pain. 2003;4:465\u201370.","journal-title":"J Pain"},{"key":"1645_CR16","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1111\/j.1526-4637.2004.04020.x","volume":"5","author":"MM Backonja","year":"2004","unstructured":"Backonja MM, Serra J. Pharmacologic management part 1: better-studied neuropathic pain diseases. Pain Med. 2004;5:S28\u201347.","journal-title":"Pain Med"},{"key":"1645_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1124\/mol.115.099630","volume":"88","author":"LM Luttrell","year":"2015","unstructured":"Luttrell LM, Maudsley S, Bohn LM. Fulfilling the promise of \u2018biased\u2019 G protein-coupled receptor agonism. Mol Pharm. 2015;88:579\u201388.","journal-title":"Mol Pharm"},{"key":"1645_CR18","first-page":"119206","volume":"119","author":"F Sakloth","year":"2020","unstructured":"Sakloth F, Polizu C, Bertherat F, Zachariou V. Regulators of G protein signaling in analgesia and addiction. Mol Pharm. 2020;119:119206.","journal-title":"Mol Pharm"},{"key":"1645_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fnmol.2020.00005","volume":"13","author":"NB Senese","year":"2020","unstructured":"Senese NB, Kandasamy R, Kochan KE, Traynor JR. Regulator of G-protein signaling (RGS) protein modulation of opioid receptor signaling as a potential target for pain management. Front Mol Neurosci. 2020;13:5.","journal-title":"Front Mol Neurosci"},{"key":"1645_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1124\/molpharm.120.000178","volume":"99","author":"M von Zastrow","year":"2021","unstructured":"von Zastrow M. Proteomic approaches to investigate regulated trafficking and signaling of G protein\u2013coupled receptors. Mol Pharmacol 2021;99:392\u20138.","journal-title":"Mol Pharmacol"},{"key":"1645_CR21","doi-asserted-by":"publisher","first-page":"E2085","DOI":"10.1073\/pnas.1707887115","volume":"115","author":"S Gaspari","year":"2018","unstructured":"Gaspari S, Purushothaman I, Cogliani V, Sakloth F, Neve RL. Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt\/\u03b2-catenin pathway. Proc Natl Acad Sci USA. 2018; 115:E2085\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1645_CR22","doi-asserted-by":"publisher","unstructured":"Han MH, Renthal W, Ring RH, Rahman Z, Psifogeorgou K, Howland D, et al. Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia. Biol Psychiatry. 2010. https:\/\/doi.org\/10.1016\/j.biopsych.2009.08.041.","DOI":"10.1016\/j.biopsych.2009.08.041"},{"key":"1645_CR23","doi-asserted-by":"publisher","first-page":"E5088","DOI":"10.1073\/pnas.1504283112","volume":"112","author":"V Mitsi","year":"2015","unstructured":"Mitsi V, Terzi D, Purushothaman I, Manouras L, Gaspari S, Neve RL. RGS9-2-controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states. Proc Natl Acad Sci USA. 2015;112:E5088\u201397.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1645_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nlm.2014.08.005","volume":"115","author":"D Terzi","year":"2014","unstructured":"Terzi D, Gaspari S, Manouras L, Descalzi G, Mitsi V, Zachariou V. RGS9-2 modulates sensory and mood related symptoms of neuropathic pain. Neurobiol Learn Mem. 2014;115:43\u20138.","journal-title":"Neurobiol Learn Mem"},{"key":"1645_CR25","doi-asserted-by":"publisher","first-page":"ENEURO.0365-20.","DOI":"10.1523\/ENEURO.0365-20.2020","volume":"8","author":"LP Sutton","year":"2021","unstructured":"Sutton LP, Khalatyan N, Savas JN, Martemyanov KA. Striatal rgs7 regulates depression-related behaviors and stress-induced reinstatement of cocaine conditioned place preference. ENeuro. 2021;8:ENEURO.0365-20.2020.","journal-title":"ENeuro."},{"key":"1645_CR26","first-page":"8","volume":"54","author":"S Hollinger","year":"2021","unstructured":"Hollinger S, Hepler JR. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharm Rev. 2021;54:8\u201359.","journal-title":"Pharm Rev"},{"key":"1645_CR27","doi-asserted-by":"crossref","unstructured":"Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, et al. Regulator of G protein signaling 4 is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc Natl Acad Sci USA. 2013;110:8254\u20139.","DOI":"10.1073\/pnas.1214696110"},{"key":"1645_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nn.3153","volume":"15","author":"M Baliki","year":"2013","unstructured":"Baliki M, Petre B, Torbey S, Herrmann K, Huang L, Schnitzer T, et al. Corticostriatal functional connectivity predicts transition to chronic pain. Nat Neurosci. 2013;15:1117\u20139.","journal-title":"Nat Neurosci"},{"key":"1645_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aaj1549","volume":"10","author":"G Descalzi","year":"2017","unstructured":"Descalzi G, Mitsi V, Purushothaman I, Gaspari S, Avrampou K, Loh YHE, et al. Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression. Sci Signal. 2017;10:1\u201318.","journal-title":"Sci Signal"},{"key":"1645_CR30","doi-asserted-by":"crossref","unstructured":"Pryce, KD. et al. Oxycodone withdrawal induces HDAC1\/HDAC2-dependent transcriptional maladaptations in the reward pathway in a mouse model of peripheral nerve injury. Nat. Neurosci. 2023:1\u201316.","DOI":"10.1038\/s41593-023-01350-3"},{"key":"1645_CR31","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/npp.2017.4","volume":"42","author":"S Gaspari","year":"2017","unstructured":"Gaspari S, Cogliani V, Manouras L, Anderson EM, Mitsi V, Avrampou K, et al. RGS9-2 modulates responses to oxycodone in pain-free and chronic pain states. Neuropsychopharmacology. 2017;42:1548\u201356.","journal-title":"Neuropsychopharmacology."},{"key":"1645_CR32","doi-asserted-by":"publisher","unstructured":"Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, et al. Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA. 2003. https:\/\/doi.org\/10.1073\/pnas.2232594100.","DOI":"10.1073\/pnas.2232594100"},{"key":"1645_CR33","doi-asserted-by":"publisher","first-page":"8291","DOI":"10.1523\/JNEUROSCI.3154-18.2019","volume":"39","author":"K Avrampou","year":"2019","unstructured":"Avrampou K, Pryce KD, Ramakrishnan A, Sakloth F, Gaspari S, Serafini RA, et al. RGS4 maintains chronic pain symptoms in rodent models. J Neurosci. 2019;39:8291\u2013304.","journal-title":"J Neurosci"},{"key":"1645_CR34","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1038\/npp.2017.60","volume":"42","author":"BA Samuels","year":"2017","unstructured":"Samuels BA, Nautiyal KM, Kruegel AC, Levinstein MR, Magalong VM, Gassaway MM, et al. The behavioral effects of the antidepressant tianeptine require the Mu-opioid receptor. Neuropsychopharmacology. 2017;42:2052\u201363.","journal-title":"Neuropsychopharmacology."},{"key":"1645_CR35","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1038\/tp.2014.30","volume":"4","author":"MM Gassaway","year":"2014","unstructured":"Gassaway MM, Rives ML, Kruegel AC, Javitch JA, Sames D. The atypical antidepressant and neurorestorative agent tianeptine is a \u03bc-opioid receptor agonist. Transl Psychiatry. 2014;4:e411\u20135.","journal-title":"Transl Psychiatry"},{"key":"1645_CR36","doi-asserted-by":"publisher","first-page":"8254","DOI":"10.1073\/pnas.1214696110","volume":"110","author":"M Stratinaki","year":"2013","unstructured":"Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, et al. Regulator of G protein signaling is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc Natl Acad Sci USA. 2013;110:8254\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1645_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1471-4159.2007.04812.x","volume":"103","author":"K Psifogeorgou","year":"2007","unstructured":"Psifogeorgou K, Papakosta P, Russo SJ, Neve RL, Kardassis D, Gold SJ, et al. RGS9-2 is a negative modulator of \u03bc-opioid receptor function. J Neurochem. 2007;103:617\u201325.","journal-title":"J Neurochem"},{"key":"1645_CR38","doi-asserted-by":"publisher","first-page":"E5088","DOI":"10.1073\/pnas.1504283112","volume":"112","author":"V Mitsi","year":"2015","unstructured":"Mitsi V, Terzi D, Purushothaman I, Manouras L, Gaspari S, Neve RL, et al. RGS9-2\u2013controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states. Proc Natl Acad Sci USA. 2015;112:E5088\u201397.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1645_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/mp.2014.184","volume":"20","author":"LC Lin","year":"2015","unstructured":"Lin LC, Sibille E. Somatostatin, neuronal vulnerability and behavioral emotionality. Mol Psychiatry. 2015;20:377\u201387.","journal-title":"Mol Psychiatry"},{"key":"1645_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0642-z","volume":"9","author":"MJ Girgenti","year":"2019","unstructured":"Girgenti MJ, Wohleb ES, Mehta S, Ghosal S, Fogaca MV, Duman RS. Prefrontal cortex interneurons display dynamic sex-specific stress-induced transcriptomes. Transl Psychiatry. 2019;9:292.","journal-title":"Transl Psychiatry"},{"key":"1645_CR41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nn.4199","volume":"19","author":"W Ren","year":"2016","unstructured":"Ren W, Centeno MV, Berger S, Wu Y, Na X, Liu X, et al. The indirect pathway of the nucleus accumbens shell amplifies neuropathic pain. Nat Neurosci. 2016;19:220\u20134.","journal-title":"Nat Neurosci"},{"key":"1645_CR42","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s00213-020-05525-9","volume":"237","author":"F Sakloth","year":"2020","unstructured":"Sakloth F, Manouras L, Avrampou K, Mitsi V, Serafini RA, Pryce KD, et al. HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice. Psychopharmacology. 2020;237:2139\u201349.","journal-title":"Psychopharmacology"},{"key":"1645_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbi.2021.12.005","volume":"100","author":"J Zhang","year":"2022","unstructured":"Zhang J, Ma J, Trinh RT, Heijnen CJ, Kavelaars A. An HDAC6 inhibitor reverses chemotherapy-induced mechanical hypersensitivity via an IL-10 and macrophage dependent pathway. Brain Behav Immun. 2022;100:287\u201396.","journal-title":"Brain Behav Immun"},{"key":"1645_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejphar.2018.02.034","volume":"825","author":"MD Sanna","year":"2018","unstructured":"Sanna MD, Galeotti N. The HDAC1\/c-JUN complex is essential in the promotion of nerve injury-induced neuropathic pain through JNK signaling. Eur J Pharm. 2018;825:99\u2013106.","journal-title":"Eur J Pharm"},{"key":"1645_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pbb.2017.08.006","volume":"160","author":"MD Sanna","year":"2017","unstructured":"Sanna MD, Guandalini L, Romanelli MN, Galeotti N. The new HDAC1 inhibitor LG325 ameliorates neuropathic pain in a mouse model. Pharm Biochem Behav. 2017;160:70\u20135.","journal-title":"Pharm Biochem Behav"},{"key":"1645_CR46","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1038\/npp.2014.45","volume":"39","author":"S Gaspari","year":"2014","unstructured":"Gaspari S, Papachatzaki MM, Koo JW, Carr FB, Tsimpanouli ME, Stergiou E, et al. Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine. Neuropsychopharmacology. 2014;39:1968\u201377.","journal-title":"Neuropsychopharmacology."},{"key":"1645_CR47","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1523\/JNEUROSCI.4146-10.2011","volume":"31","author":"K Psigfogeorgou","year":"2011","unstructured":"Psigfogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ, et al. A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. J Neurosci. 2011;31:5617\u201324.","journal-title":"J Neurosci"},{"key":"1645_CR48","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.pain.2014.02.019","volume":"155","author":"PC Chang","year":"2014","unstructured":"Chang PC, Pollema-Mays SL, Centeno MV, Procissi D, Contini M, Baria AT, et al. Role of nucleus accumbens in neuropathic pain: linked multi-scale evidence in the rat transitioning to neuropathic pain. Pain. 2014;155:1128\u201339.","journal-title":"Pain."},{"key":"1645_CR49","doi-asserted-by":"publisher","first-page":"12165","DOI":"10.1523\/JNEUROSCI.3576-06.2006","volume":"26","author":"MN Baliki","year":"2006","unstructured":"Baliki MN, Chialvo DR, Geha PY, Levy RM, Harden RN, Parrish TB, et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci. 2006;26:12165\u201373.","journal-title":"J Neurosci"},{"key":"1645_CR50","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuropharm.2017.02.012","volume":"117","author":"P Pallaki","year":"2017","unstructured":"Pallaki P, Georganta EM, Serafimidis I, Papakonstantinou MP, Papanikolaou V, Koutloglou S, et al. A novel regulatory role of RGS4 in STAT5B activation, neurite outgrowth and neuronal differentiation. Neuropharmacology. 2017;117:408\u201321.","journal-title":"Neuropharmacology."},{"key":"1645_CR51","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cellsig.2005.07.003","volume":"18","author":"Z Georgoussi","year":"2006","unstructured":"Georgoussi Z, Leontiadis L, Mazarakou G, Merkouris M, Hyde K, Hamm H. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling. Cell Signal. 2006;18:771\u201382.","journal-title":"Cell Signal"},{"key":"1645_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1523\/JNEUROSCI.18-01-00488.1998","volume":"18","author":"XF Zhang","year":"1998","unstructured":"Zhang XF, Hu XT, White FJ. Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. J Neurosci. 1998;18:488\u201398.","journal-title":"J Neurosci"},{"key":"1645_CR53","doi-asserted-by":"publisher","first-page":"19034","DOI":"10.1523\/JNEUROSCI.2454-13.2013","volume":"33","author":"Y Goffer","year":"2013","unstructured":"Goffer Y, Xu D, Eberle SE, D\u2019amour J, Lee M, Tukey D, et al. Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state. J Neurosci. 2013;33:19034\u201344.","journal-title":"J Neurosci"},{"key":"1645_CR54","doi-asserted-by":"publisher","first-page":"7851","DOI":"10.1038\/s41380-021-01177-z","volume":"26","author":"D Garc\u00eda-Gonz\u00e1lez","year":"2021","unstructured":"Garc\u00eda-Gonz\u00e1lez D, Dumitru I, Zuccotti A, Yen TY, Herranz-P\u00e9rez V, Tan LL, et al. Neurogenesis of medium spiny neurons in the nucleus accumbens continues into adulthood and is enhanced by pathological pain. Mol Psychiatry. 2021;26:7851.","journal-title":"Mol Psychiatry"},{"key":"1645_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/FBP.0b013e3282ee2aa8","volume":"18","author":"HD Schmidt","year":"2007","unstructured":"Schmidt HD, Duman RS. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharm. 2007;18:391\u2013418.","journal-title":"Behav Pharm"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01645-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01645-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T14:06:08Z","timestamp":1695391568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01645-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1645"],"URL":"https:\/\/doi.org\/10.1038\/s41386-023-01645-w","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"VZ declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. JAJ is an inventor on tianeptine-related patents owned by Columbia University. RAS, ME, EAP, FS, LS, and VZ declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}